Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fabpitt
    Junior Member
    • Nov 2017
    • 1

    #1

    batch effects

    Hello, I'm a student.
    I have an expression matrix of 1208 samples (1095 tumor and 113 normal) downloaded from TCGA (RNA-Seq) and I have to adjust for batch effects. http://bioinformatics.mdanderson.org/tcgambatch/ suggests that there are 3 batches: type(tumor/normal), plateId and TSS but in a different forum, a boy said me that he has never noticed these batch effects.
    So I'm a bit confused...
    Is there anyone who can explain me how to find batch effects? I know that I can look for them with PCA but I have no idea how to interpret the graph. Can I consider tumor and normal as batch effects?
    Thanks in advance
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #2
    No; tumour and normal samples are not unwanted technical variation. They are phenotypes of biological interest. A lot of analyses have been done with TCGA data and published, so I think you could ignore batch effects for your analysis as everyone else has done. If you don't understand a PCA plot, then you shouldn't try to estimate batch effects, which is much more complicated to do correctly.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      How Immunogenomics Decodes Immunity’s Genetic Blueprint
      by SEQadmin2




      The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

      This convergence of genetics, immunology, and computation...
      Today, 05:41 AM
    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-24-2026, 10:32 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-20-2026, 11:17 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-18-2026, 10:05 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    49 views
    0 reactions
    Last Post SEQadmin2  
    Working...